NXL
NXL
NASDAQ · Health Care

Nexalin Technology Inc

$0.35
0.00 (-0.11%)
As of Aug 14, 10:23 PM ET ·
Analyst Consensus
Strong Buy
5
Analysts
Moderate
Coverage
Buy 4 80%
Hold 1 20%
Sell 0 0%
Price Target
Analyst Price Target +2,320.0% upside
Low Target $5.74
Average Target $8.47
High Target $10.28
Current Price $0.35
Current
$0.35
Target
$8.47
$5.74 $8.47 avg $10.28
Scenario Analysis
Bear Case
$5.74
1,540.0%
Low target
Base Case
$8.47
+2,320.0%
Avg target
Bull Case
$10.28
+2,837.1%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$2.00
-82.5% from high
52-Week Low
$0.31
+14.8% from low
Target vs 52W High
$8.47
+323.5% vs high
Peer Consensus — Health Care
Stock Consensus Analysts Buy % Target Upside
UNH
UnitedHealth Group Inc
Strong Buy 34 79% $293.85 -26.9%
ABT
Abbott Laboratories
Buy 33 73% $123.47 +11.0%
ISRG
Intuitive Surgical Inc
Buy 40 70% $219.77 -44.3%
SYK
Stryker Corp
Strong Buy 34 82% $338.36 -0.3%
CVS
Cvs Health Corp
Strong Buy 33 85% $162.09 +66.8%
MDT
Medtronic Plc
Buy 34 65% $192.46 +110.9%
MCK
Mckesson Corp
Strong Buy 23 87% $307.39 -64.6%
HCA
Hca Healthcare Inc
Buy 30 57% $118.82 -70.6%